ADD CONDITION

items per page

Extra Strength Scar Prevention

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Gel
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2017
Label revision date
April 28, 2017
Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Gel
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2017
Label revision date
April 28, 2017
Manufacturer
ridge properties
Registration number
part348
NDC root
69804-065

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Therefore, I cannot create a summary about a drug without any details. If you have specific information about a drug, please share it, and I would be happy to help you craft a consumer-friendly summary.

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

If you have any questions or need further information about this medication, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

It seems that the specific dosage and administration details for the medication you are inquiring about are not available in the provided information. Typically, this information would include how much of the medication to take, how to take it (for example, orally or through an injection), and how often to take it.

To ensure you use the medication safely and effectively, it's important to refer to the accompanying image or consult your healthcare provider for the exact instructions tailored to your needs. Always follow their guidance to achieve the best results from your treatment.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for you.

Side Effects

You can feel reassured that there are no specific side effects or additional adverse reactions associated with this medication. This means that, based on current information, you are not likely to experience any unwanted effects while using it. Always consult with your healthcare provider if you have any concerns or experience unusual symptoms.

Warnings and Precautions

It appears that there are no specific warnings, precautions, or instructions provided in the information available. However, it's always important to be aware of potential side effects or reactions when taking any medication. If you experience any unusual symptoms or have concerns about your health while using this medication, it’s best to stop taking it and consult your doctor for guidance.

In case of an emergency or severe reaction, seek immediate medical help. Always keep open communication with your healthcare provider about any changes in your health or any medications you are taking. Your safety and well-being are the top priority.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to err on the side of caution when it comes to your health. Remember, if you have any concerns or questions about your medication, don't hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

When it comes to using this medication during pregnancy, there is no specific information available about its safety, dosage adjustments, or any special precautions you should take. This means that the effects of the medication on you and your developing baby are not well understood.

If you are pregnant or planning to become pregnant, it’s important to discuss any medications you are taking with your healthcare provider. They can help you weigh the potential risks and benefits to ensure the best care for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks it may pose to your infant.

As always, if you have any concerns or questions about using this product while breastfeeding, it's a good idea to consult with your healthcare provider for personalized advice.

Pediatric Use

It's important to note that the safety and effectiveness of this product have not been established for children. This means that there hasn't been enough research to confirm whether it is safe or works well for pediatric patients (children and adolescents). As a parent or caregiver, you should be cautious and consult with a healthcare professional before using this product for anyone under the age of 18.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Specifically, if you have reduced creatinine clearance (a measure of how well your kidneys are filtering waste), you should be closely monitored by your healthcare provider.

Before starting treatment and during your care, your renal function will be tested to ensure your kidneys are working properly. If you have significant renal impairment, a lower dose of the medication is recommended to help prevent any potential complications. Always communicate with your healthcare team about your kidney health to ensure safe and effective treatment.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular liver function tests (which check how well your liver is working) to ensure your safety while using any medication.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known interactions between this medication and other drugs or laboratory tests. However, every individual is different, and your healthcare provider can help ensure that your treatment is safe and effective for you. Always feel free to ask questions and share your complete list of medications and any tests you may be undergoing.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 20°C to 25°C (68°F to 77°F). It's important to protect it from light, so keep it in its original packaging or a dark container. Always make sure the container is tightly closed when not in use to maintain its integrity.

Once you open the container, please remember to discard it after use to ensure safety and effectiveness. Following these guidelines will help you handle the product safely and maintain its quality.

Additional Information

No further information is available.

FAQ

What should I know about the use of this drug during pregnancy?

There is no specific information provided regarding the use of this drug during pregnancy, including safety concerns or dosage modifications.

Is this drug safe for nursing mothers?

There are no specific warnings or recommendations regarding the use of this product in nursing mothers.

What precautions should I take if I have renal impairment?

If you have renal impairment, dosage adjustments may be necessary, and renal function tests should be performed prior to and during treatment.

What are the storage conditions for this drug?

Store the drug at 20°C to 25°C (68°F to 77°F), protect it from light, keep the container tightly closed, and discard it after opening.

Are there any specific contraindications for this drug?

No specific contraindications are listed for this drug.

What should I do if I experience side effects?

The text does not provide specific side effects or warnings, so consult your doctor for guidance.

Is this drug suitable for pediatric patients?

Pediatric use has not been established, and safety and effectiveness in pediatric patients have not been determined.

What about geriatric use of this drug?

No specific information regarding geriatric use, dosage adjustments, or safety concerns is provided.

Packaging Info

Below are the non-prescription pack sizes of Extra Strength Scar Prevention (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Scar Prevention.
Details

Drug Information (PDF)

This file contains official product information for Extra Strength Scar Prevention, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the overall clinical context when prescribing this medication.

Dosage and Administration

The prescribing information does not contain specific dosage and administration details. Healthcare professionals are advised to refer to the accompanying image for comprehensive dosage guidelines and administration techniques. It is essential to follow the outlined instructions in the image to ensure proper dosing and administration practices.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

Healthcare professionals should be aware that specific warnings and precautions associated with the use of this medication are not detailed in the provided information. It is essential to remain vigilant and consider the patient's overall health status and any potential contraindications when prescribing this treatment.

In the absence of explicit laboratory tests or monitoring parameters, healthcare providers are encouraged to utilize standard clinical judgment and relevant diagnostic assessments to ensure patient safety. Regular monitoring of the patient's condition and response to therapy is advisable, particularly in populations that may be at increased risk for adverse effects.

In situations where patients exhibit concerning symptoms or adverse reactions, it is imperative to seek emergency medical assistance promptly. Additionally, if a patient experiences any unexpected or severe side effects, they should be advised to discontinue use of the medication and contact their healthcare provider immediately for further evaluation and guidance.

Overall, maintaining open communication with patients regarding their treatment and any potential risks is crucial for optimizing therapeutic outcomes and ensuring patient safety.

Side Effects

No specific side effects have been identified in the warnings section for this product. Additionally, there are no further adverse reactions or important notes regarding side effects reported in the available data. As such, the safety profile remains unremarkable with respect to adverse reactions.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Scar Prevention (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Scar Prevention.
Details

Pediatric Use

Pediatric use has not been established for this product. Safety and effectiveness in pediatric patients have not been determined.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients receiving treatment. It is essential that patients with reduced creatinine clearance are closely monitored throughout the course of therapy. Additionally, renal function tests should be performed prior to and during treatment in these patients to ensure safety and efficacy. A reduced dose is recommended for patients with significant renal impairment to mitigate the risk of adverse effects associated with decreased kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage and handling to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and protected from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Extra Strength Scar Prevention, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Extra Strength Scar Prevention, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.